China Medical Aesthetic Injection Market Operation Prospect and Investment Risk Assessment Report 2023 2030
Publisher]: Zhongying Xinhe Research Network.
The content part is abridged and detailed, please refer to the full information published by Zhongying Xinhe Research Network!】
Chapter 1: Medical Aesthetic Injections Industry Overview and Data Description**.
1.1 Definition of medical aesthetic injection industry.
1.1.1 Definition of medical aesthetic injections.
1.1.2 Analysis of the concept of similarity in medical aesthetic injections.
1.1.3 Classification of medical aesthetic injections.
1.2 Explanation of professional terms for medical aesthetic injections.
1.3 Scoping note for this report.
1.4 Description of the data** and statistical standards in this report.
1.4.1 Authoritative data from this report**.
1.4.2 Methodology and statistical standards for this report.
Chapter 2: Macro Environment Analysis (PEST) of China's Medical Aesthetic Injectables Industry
2.1 Analysis of the policy environment of China's medical aesthetic injection industry.
2.1.1 Introduction to the regulatory system and institutions of China's medical aesthetic injection industry.
1) The competent authority of China's medical aesthetic injection industry.
2) Self-regulatory organization of China's medical aesthetic injection industry.
2.1.2 The status quo of the construction of the industry standard system for medical aesthetic injections in China.
1) Construction of standard system for medical aesthetic injections in China.
2) Summary of the current standards for medical aesthetic injections in China.
3) The standard for Chinese medical aesthetic injections will soon be implemented.
4) Interpretation of key standards for Chinese medical aesthetic injections.
2.1.3 Summary of laws and administrative regulations of China's medical aesthetic injection industry.
2.1.4 Summary of relevant national policies and plans for China's medical aesthetic injection industry.
1) Summary of relevant policies for the development of China's medical aesthetic injection industry at the national level.
2) Summary of relevant plans for the development of China's medical aesthetic injection industry at the national level.
2.1.5 Analysis of key policies at the national level in China's medical aesthetic injection industry.
2.1.6 Analysis of the key planning of China's medical aesthetic injection industry at the national level.
2.1.7 Regional policy heat map of China's medical aesthetic injection industry.
2.1.8 Summary of the impact of the policy environment on the development of China's medical aesthetic injection industry.
2.2 Analysis of the economic environment of China's medical aesthetic injection industry.
2.2.1 Current status of China's macroeconomic development.
2.2.2 Macroeconomic outlook for China.
2.2.3 Analysis of the correlation between the development of the medical aesthetic injection industry and the macroeconomy.
2.3 Analysis of the social environment of China's medical aesthetic injection industry.
2.3.1 Analysis of the social environment of China's medical aesthetic injection industry.
2.3.2 Summary of the impact of social environment on the medical aesthetic injection industry.
2.4 Analysis of the technology environment of China's medical aesthetic injection industry.
2.4.1 Technology process and process of China's medical aesthetic injection industry**.
2.4.2 The technical life cycle of China's medical aesthetic injection industry.
2.4.3 Analysis of key technologies in China's medical aesthetic injection industry.
2.4.4 R&D investment in China's medical aesthetic injection industry.
2.4.5 Scientific research and innovation achievements in China's medical aesthetic injection industry.
1) Patent application for China's medical aesthetic injection industry was published.
2) Popular applicants in China's medical aesthetic injection industry.
3) Popular technology in China's medical aesthetic injection industry.
4) Characteristics of patent value in China's medical aesthetic injection industry.
2.4.6 The direction of the technical development plan of China's medical aesthetic injection industry.
2.4.7 Summary of the impact of the technical environment on the development of China's medical aesthetic injection industry.
Chapter 3: Research on the development status of the global medical aesthetic injection industry and market trend insights.
3.1 Introduction to the development history of the global medical aesthetic injection industry.
3.2 Macro environment background of the global medical aesthetic injection industry.
3.2.1 Overview of the economic environment of the global medical aesthetic injection industry.
3.2.2 Overview of the political and legal environment of the global medical aesthetic injection industry.
3.2.3 Overview of the technical environment of the global medical aesthetic injection industry.
3.2.4 Analysis of the impact of the new crown epidemic on the global medical aesthetic injection industry.
3.3 Analysis of the development status and market size of the global medical aesthetic injection industry.
3.4 Regional development pattern and key regional market research of the global medical aesthetic injection industry.
3.4.1 The regional development pattern of the global medical aesthetic injection industry.
3.4.2 The development of the market in key regions of the global medical aesthetic injection industry.
1) Analysis of the development status of the medical aesthetic injection industry in the United States.
2) Analysis of the development status of the Brazilian medical aesthetic injection industry.
3) Analysis of the development status of the Japanese medical aesthetic injection industry.
3.5 Global medical aesthetic injection industry market competition pattern and case studies of key companies.
3.5.1 The competitive landscape of the global medical aesthetic injection industry.
3.5.2 Mergers and acquisitions of global medical aesthetic injection companies.
3.5.3 Key enterprise cases in the global medical aesthetic injection industry (customizable).
3.6 Prediction of the development trend and market prospect of the global medical aesthetic injection industry**.
3.6.1 Prediction of the development trend of the global medical aesthetic injection industry.
3.6.2 Market prospect of the global medical aesthetic injection industry**.
3.7 Lessons from the development experience of the global medical aesthetic injection industry.
Chapter 4: Analysis of the market supply and demand situation and development pain points of China's medical aesthetic injection industry.
4.1 The development history of China's medical aesthetic injection industry.
4.2 The external situation of China's medical aesthetic injection industry.
4.2.1 Import status of medical aesthetic injection products in China.
4.2.2 China's export status of medical aesthetic injection products.
4.2.3 Influencing factors and development trends of import and export of China's medical aesthetic injection industry.
4.3 Types of market players and entry methods in China's medical aesthetic injection industry.
4.4 The number and scale of market players in China's medical aesthetic injection industry.
4.5 Analysis of the supply level of China's medical aesthetic injection industry.
4.6 Analysis of the demand for China's medical aesthetic injection industry.
4.7 The market size of China's medical aesthetic injection industry.
4.8 Profitability analysis of China's medical aesthetic injection industry.
4.9 Analysis of the market pain points of China's medical aesthetic injection industry.
Chapter 5: Interpretation of the market competition and development pattern of China's medical aesthetic injection industry.
5.1 Analysis of the market competition pattern of China's medical aesthetic injection industry.
5.2 Analysis of market concentration in China's medical aesthetic injection industry.
5.3 Analysis of Porter's Five Forces Model in China's Medical Aesthetic Injection Industry.
5.3.1 The bargaining power of the best merchants in China's medical aesthetic injection industry.
5.3.2 The bargaining power of buyers in China's medical aesthetic injection industry.
5.3.3 Threat of new entrants in China's medical aesthetic injection industry.
5.3.4 Threat of substitutes in China's medical aesthetic injection industry.
5.3.5 The competitiveness of competitors in China's medical aesthetic injection industry.
5.3.6 Summary of the competitive situation of China's medical aesthetic injection industry.
5.4 Investment, financing, mergers and acquisitions in China's medical aesthetic injection industry.
5.4.1 Innovation and development fund for China's medical aesthetic injection industry**.
5.4.2 Investment and financing development of China's medical aesthetic injection industry.
1) The main investment and financing entity of China's medical aesthetic injection industry.
2) Investment and financing methods in China's medical aesthetic injection industry.
3) Summary of investment and financing events in China's medical aesthetic injection industry.
4) Summary of investment and financing information of China's medical aesthetic injection industry.
5.4.3 Mergers and acquisitions of China's medical aesthetic injection industry.
1) Summary of mergers and acquisitions in China's medical aesthetic injection industry.
2) Analysis of the drivers of mergers and acquisitions in China's medical aesthetic injection industry.
3) Case study of mergers and acquisitions in China's medical aesthetic injection industry.
4) Prediction of the trend of mergers and acquisitions in China's medical aesthetic injection industry.
5.5 Participation in the international market competition of Chinese medical aesthetic injection companies.
5.6 Domestic substitution layout of China's medical aesthetic injection industry.
Chapter 6: Panorama of China's medical aesthetic injection industry chain and its industrial chain layout.
6.1 Analysis of the structural attributes (industrial chain) of China's medical aesthetic injection industry.
6.1.1 Sorting out the chain structure of China's medical aesthetic injection industry.
6.1.2 Ecological map of China's medical aesthetic injection industry chain.
6.2 Analysis of the value attribute (value chain) of China's medical aesthetic injection industry.
6.2.1 Analysis of the cost structure of China's medical aesthetic injection industry.
6.2.2 Analysis of the conduction mechanism of Chinese medical aesthetic injections**.
6.2.3 Value chain analysis of China's medical aesthetic injection industry.
6.3 Analysis of the upstream ** market of China's medical aesthetic injection industry.
6.3.1 Hyaluronic acid raw material market analysis.
6.3.2 Botulinum toxin raw material market analysis.
6.3.3 Other raw materials market analysis.
6.4 Analysis of the Midstream Segment of China's Medical Aesthetic Injectables Industry by Institution Type.
6.4.1 Distribution of medical aesthetic injections in China.
6.4.2 Market analysis of hyaluronic acid injection products.
6.4.3 Botulinum toxin injection product market analysis.
6.4.4 Market analysis of complementary injectable products.
6.5 Market analysis of downstream medical aesthetic service institutions in China's medical aesthetic injection industry.
6.5.1 Overview of medical aesthetic service providers in China.
6.5.2 The development status of medical aesthetic service institutions in China.
6.5.3 Competition among China's medical aesthetic service institutions.
6.5.4 Trend and prospect analysis of China's medical aesthetic service institutions.
Chapter 7: Case Study of Key Companies in China's Medical Aesthetic Injectables Industry.
7.1 Sorting out and comparing the layout of key enterprises in China's medical aesthetic injections.
7.2 Case study of the layout of key enterprises in China's medical aesthetic injections (customizable, in no particular order).
7.2.1 Aimeike Technology Development Co., Ltd. ***
1) Enterprise development history and.
2) Enterprise development history and basic information.
3) The business structure and operating status of the enterprise.
4) The layout of the industrial chain of the company's medical aesthetic injection business, technology, products and services.
5) The supply status of the company's medical aesthetic injection business.
6) The sales layout of the company's medical aesthetic injection business.
7) Analysis of the advantages and disadvantages of the company's medical aesthetic injection business layout.
7.2.2 Bloomage Biotechnology Co., Ltd. ***
1) Enterprise development history and.
2) Enterprise development history and basic information.
3) The business structure and operating status of the enterprise.
4) The layout of the industrial chain of the company's medical aesthetic injection business, technology, products and services.
5) The business model of the company's medical aesthetic injections.
6) The sales layout of the company's medical aesthetic injection business.
7) Analysis of the advantages and disadvantages of the company's medical aesthetic injection business layout.
7.2.3 Shanghai Haohai Biotechnology Co., Ltd. ***
1) Enterprise development history and.
2) Enterprise development history and basic information.
3) The business structure and operating status of the enterprise.
4) The layout of the industrial chain of the company's medical aesthetic injection business, technology, products and services.
5) The business model of the company's medical aesthetic injections.
6) The sales layout of the company's medical aesthetic injection business.
7) Analysis of the advantages and disadvantages of the company's medical aesthetic injection business layout.
7.2.4 Beijing Monborun Biotechnology***
1) Enterprise development history and.
2) Enterprise development history and basic information.
3) The business structure and operating status of the enterprise.
4) The layout of the industrial chain of the company's medical aesthetic injection business, technology, products and services.
5) The business model of the company's medical aesthetic injections.
6) The sales layout of the company's medical aesthetic injection business.
7) Analysis of the advantages and disadvantages of the company's medical aesthetic injection business layout.
7.2.5 Hangzhou Caton Biological Products***
1) Enterprise development history and.
2) Enterprise development history and basic information.
3) The business structure and operating status of the enterprise.
4) The layout of the industrial chain of the company's medical aesthetic injection business, technology, products and services.
5) The business model of the company's medical aesthetic injections.
6) The sales layout of the company's medical aesthetic injection business.
7) Analysis of the advantages and disadvantages of the company's medical aesthetic injection business layout.
7.2.6 Hangzhou Concord Medical Supplies***
1) Enterprise development history and.
2) Enterprise development history and basic information.
3) The business structure and operating status of the enterprise.
4) The layout of the industrial chain of the company's medical aesthetic injection business, technology, products and services.
5) The business model of the company's medical aesthetic injections.
6) The sales layout of the company's medical aesthetic injection business.
7) Analysis of the advantages and disadvantages of the company's medical aesthetic injection business layout.
7.2.7 Changzhou Institute of Pharmaceutical Research***
1) Enterprise development history and.
2) Enterprise development history and basic information.
3) The business structure and operating status of the enterprise.
4) The layout of the industrial chain of the company's medical aesthetic injection business, technology, products and services.
5) The business model of the company's medical aesthetic injections.
6) The sales layout of the company's medical aesthetic injection business.
7) Analysis of the advantages and disadvantages of the company's medical aesthetic injection business layout.
7.2.8 Shandong Kailepu Bioengineering***
1) Enterprise development history and.
2) Enterprise development history and basic information.
3) The business structure and operating status of the enterprise.
4) The layout of the industrial chain of the company's medical aesthetic injection business, technology, products and services.
5) The business model of the company's medical aesthetic injections.
6) The sales layout of the company's medical aesthetic injection business.
7) Analysis of the advantages and disadvantages of the company's medical aesthetic injection business layout.
7.2.9 Lanzhou Institute of Biological Products Co., Ltd.
1) Enterprise development history and.
2) Enterprise development history and basic information.
3) The business structure and operating status of the enterprise.
4) The layout of the industrial chain of the company's medical aesthetic injection business, technology, products and services.
5) The business model of the company's medical aesthetic injections.
6) The sales layout of the company's medical aesthetic injection business.
7) Analysis of the advantages and disadvantages of the company's medical aesthetic injection business layout.
7.2.10 Changchun Shengboma Biomaterials***
1) Enterprise development history and.
2) Enterprise development history and basic information.
3) The business structure and operating status of the enterprise.
4) The layout of the industrial chain of the company's medical aesthetic injection business, technology, products and services.
5) The business model of the company's medical aesthetic injections.
6) The sales layout of the company's medical aesthetic injection business.
7) Analysis of the advantages and disadvantages of the company's medical aesthetic injection business layout.
Chapter 8: China Medical Aesthetic Injectables Industry Market Outlook and Investment Strategic Planning Suggestions.
8.1 SWOT analysis of China's medical aesthetic injection industry.
8.2 Evaluation of the development potential of China's medical aesthetic injection industry.
8.3 Development prospects of China's medical aesthetic injection industry**.
8.4 Prediction of the development trend of China's medical aesthetic injection industry.
8.5 Barriers to entry and exit in China's medical aesthetic injection industry.
8.6 Investment risk warning of China's medical aesthetic injection industry.
8.7 Evaluation of the investment value of China's medical aesthetic injection industry.
8.8 Analysis of investment opportunities in China's medical aesthetic injection industry.
8.8.1. Investment opportunities in the weak links of the industrial chain of the medical aesthetic injection industry.
8.8.2 Investment opportunities in the subdivision of the medical aesthetic injection industry.
8.8.3. Investment opportunities in the regional market of the medical aesthetic injection industry.
8.8.4. Blank spot investment opportunities in the medical aesthetic injection industry.
8.9 Investment Strategies and Suggestions for China's Medical Aesthetic Injection Industry.
8.10 Suggestions for the sustainable development of China's medical aesthetic injection industry.
Table of Contents of Charts. Figure 1: Definition of aesthetic injections.
Figure 2: Conceptual analysis of medical aesthetic injections.
Figure 3: Classification of aesthetic injections.
Figure 4: Glossary of medical aesthetic injections.
Figure 5: Scoping of the study.
Exhibit 6: Summary of authoritative data from this report**.
Figure 7: Description of the main research methods and statistical criteria in this report.
Figure 8: Regulatory system of China's medical aesthetic injection industry.
Exhibit 9: Competent authorities of China's medical aesthetic injection industry.
Exhibit 10: Self-Regulatory Organization of China's Medical Aesthetic Injectables Industry.
Figure 11: Construction of China's standard system for medical aesthetic injections.
Figure 12: Summary of current standards for medical aesthetic injections in China.
Figure 13: China Medical Aesthetic Injection Standards are about to be implemented.
Figure 14: Interpretation of key standards for medical aesthetic injections in China.
Figure 15: Summary of national-level development policies for China's medical aesthetic injection industry as of 2023.
Figure 16: Summary of the national-level development plan of China's medical aesthetic injection industry as of 2023.
Figure 17: Summary of the impact of the policy environment on the development of China's medical aesthetic injection industry.
Figure 18: Current status of China's macroeconomic development.
Exhibit 19: China's macroeconomic outlook.
Exhibit 20: Analysis of the correlation between the development of the medical aesthetic injection industry and the macroeconomy.
Exhibit 21: Analysis of the social environment of China's medical aesthetic injection industry.
Exhibit 22: Summary of the impact of the social environment on the medical aesthetic injectables industry.
Figure 23: Technology Process Flow of China's Medical Aesthetic Injection Industry**.
Exhibit 24: Analysis of key technologies in China's medical aesthetic injection industry.
Figure 25: R&D investment and innovation status of China's medical aesthetic injection industry.
Exhibit 26: Patent applications for medical aesthetic injections in China.
Exhibit 27: Top applicants for medical aesthetic injections in China.
Exhibit 28: Popular technologies for medical aesthetic injections in China.
Exhibit 29: Patent value characteristics of China's medical aesthetic injection industry.
Exhibit 30: Summary of the impact of the technology environment on the development of China's medical aesthetic injection industry.
Exhibit 31: The development history of the global medical aesthetic injection industry.
Exhibit 32: Overview of the economic environment of the global medical aesthetic injectables industry.
Exhibit 33: Overview of the political and legal environment of the global medical aesthetic injectables industry.
Exhibit 34: Overview of the technical environment in the global medical aesthetic injectables industry.
Exhibit 35: Analysis of the impact of the pandemic on the global medical aesthetic injectables industry.
Exhibit 36: Development status of the global medical aesthetic injection industry.
Exhibit 37: Global Medical Aesthetic Injectables Industry Market Size Analysis.
Exhibit 38: Regional development pattern of the global medical aesthetic injection industry.
Exhibit 39: Global Medical Aesthetic Injectables Industry Market Analysis by Key Regions.
Exhibit 40: Competitive landscape of the global medical aesthetic injectables industry.
Exhibit 41: Global mergers and acquisitions of medical aesthetic injection companies.
Figure 42: Forecast of the development trend of the global medical aesthetic injection industry.
Exhibit 43: Global Medical Aesthetic Injectables Market Outlook 2023-2030**.
Figure 44: The development history of China's medical aesthetic injection industry.
Exhibit 45: Import and export commodity names and HS codes of China's medical aesthetic injection industry.
Figure 46: Analysis of the influencing factors and development trends of the import and export of China's medical aesthetic injection industry.
Exhibit 47: Types of market players and entry methods in China's medical aesthetic injection industry.
Figure 48: Number of manufacturers in China's medical aesthetic injection industry.
Exhibit 49: Analysis of the pain points of market development in China's medical aesthetic injection industry.
Exhibit 50: Analysis of the market competition pattern of China's medical aesthetic injection industry.
Exhibit 51: Market concentration analysis of China's medical aesthetic injection industry.
Exhibit 52: Bargaining power of China's medical aesthetic injection industry leaders.
Exhibit 53: Bargaining power of buyers in China's medical aesthetic injection industry.
Exhibit 54: Threat of new entrants to China's medical aesthetic injectables industry.
Exhibit 55: Alternative Threats to China's Medical Aesthetic Injectables Industry.
Exhibit 56: Competitiveness of Chinese medical aesthetic injection competitors.
Exhibit 57: Summary of the competitive situation of China's medical aesthetic injection industry.
Exhibit 58: Mergers and acquisitions of China's medical aesthetic injection industry.
Exhibit 59: Participation in the international market competition of Chinese medical aesthetic injection companies.
Exhibit 60: Chain structure of China's medical aesthetic injection industry.
Figure 61: Ecological map of China's medical aesthetic injection industry chain.
Exhibit 62: Cost structure analysis of China's medical aesthetic injection industry.
Exhibit 63: Value chain analysis of China's medical aesthetic injection industry.
Exhibit 64: Summary of the impact of the upstream ** of China's medical aesthetic injection industry.
Exhibit 65: Segment distribution of medical aesthetic injections in China.
Figure 66: Layout and comparison of key companies in China's medical aesthetic injections.
Chart 67: The development history of Aimeike Technology Development Co., Ltd.
Exhibit 68: Basic information table of Aimeike Technology Development Co., Ltd.
Exhibit 69: Shareholding structure, governance structure, and organizational structure of Aimeike Technology Development Co., Ltd.
Exhibit 70: Overall operating conditions of Aimeike Technology Development Co., Ltd.
Exhibit 71: The overall business structure of Aimeike Technology Development Co., Ltd.***.
Chart 72: Aimeike Technology Development Co., Ltd.*** Medical Aesthetic Injection Business Technology, Product Service, Industrial Chain Layout.
Chart 73: Aimeike Technology Development Co., Ltd.*** medical aesthetic injection business supply layout.
Chart 74: Sales layout of Aimeike Technology Development Co., Ltd.*** medical aesthetic injection business.
Chart 75: Analysis of the advantages and disadvantages of the business layout of Aimeike Technology Development Co., Ltd.
Chart 76: Development history of Bloomage Biotechnology Co., Ltd.
Exhibit 77: Bloomage Biotechnology Co., Ltd.*** basic information table.
Chart 78: Bloomage Biotechnology Co., Ltd.*** Shareholding Structure, Governance Structure and Organizational Structure.
Chart 79: The overall operating conditions of Bloomage Biotechnology Co., Ltd.
Chart 80: The overall business structure of Bloomage Biotechnology Co., Ltd.
Chart 81: Bloomage Biotechnology Co., Ltd.*** Medical Aesthetic Injection Business Technology, Product Service Industry Chain Layout.
Exhibit 82: Bloomage Biotechnology Co., Ltd.'s supply layout of medical aesthetic injection business.
Chart 83: Sales layout of Bloomage Biotechnology Co., Ltd.'s medical aesthetic injection business.
Chart 84: Analysis of the advantages and disadvantages of Bloomage Biotechnology's medical aesthetic injection business layout.
Exhibit 85: Development history of Shanghai Haohai Biotechnology Co., Ltd.
Exhibit 86: Shanghai Haohai Biotechnology Co., Ltd. *** basic information table.
Chart 87: Shareholding structure of Shanghai Haohai Biotechnology Co., Ltd. Governance structure Organizational structure.
Exhibit 88: Shanghai Haohai Biotechnology Co., Ltd.*** overall operating conditions.
Exhibit 89: The overall business structure of Shanghai Haohai Biotechnology Co., Ltd.
Chart 90: Shanghai Haohai Biotechnology Co., Ltd.*** Medical Aesthetic Injection Business Technology, Product Service, Industrial Chain Layout.
Chart 91: Shanghai Haohai Biotechnology Co., Ltd.'s supply layout of medical aesthetic injection business.
Chart 92: Shanghai Haohai Biotechnology Co., Ltd.'s sales layout of medical aesthetic injection business.
Chart 93: Analysis of the advantages and disadvantages of Shanghai Haohai Biotechnology Co., Ltd.'s medical aesthetic injection business layout.
Exhibit 94: The development history of Beijing Monborun Biotechnology***.
Exhibit 95: Basic information table of Beijing Momborun Biotechnology***.
Exhibit 96: Shareholding structure, governance structure, and organizational structure of Beijing Monborun Biotechnology Co., Ltd.
Exhibit 97: Overall operating conditions of Beijing Momborun Biotech***.
Exhibit 98: The overall business structure of Beijing Monborun Biotech***.
Exhibit 99: Beijing Monborun Biotechnology*** Medical Aesthetic Injection Business Technology, Product Service Industry Chain Layout.
Exhibit 100: Beijing Momborun Biotechnology *** medical aesthetic injection business supply layout.
Exhibit 101: Sales layout of Beijing Momborun Biotech's medical aesthetic injection business.
Exhibit 102: Analysis of the advantages and disadvantages of the business layout of Beijing Mengborun Biotechnology*** medical aesthetic injections.
Figure 103: Development history of Hangzhou Kraton biological products.
Exhibit 104: Basic information table of Hangzhou Caton biological products***.
Exhibit 105: Hangzhou Caton Bioproducts*** Shareholding Structure, Governance Structure, Organizational Structure.
Chart 106: Overall operating conditions of Hangzhou Caton Bioproducts***.
Exhibit 107: Overall business structure of Hangzhou Caton Bioproducts***.
Chart 108: Hangzhou Caton Biologics *** Medical Aesthetic Injection Business Technology, Products and Services Industrial Chain Layout.
Exhibit 109: Supply layout of Hangzhou Kraton Bioproducts*** medical aesthetic injection business.
Chart 110: Sales layout of Hangzhou Caton Biologics*** medical aesthetic injection business.
Chart 111: Analysis of the advantages and disadvantages of Hangzhou Kraton Biologics*** medical aesthetic injection business layout.
Exhibit 112: Development history of Hangzhou Concord Medical Supplies***.
Exhibit 113: Basic information table of Hangzhou Concord Medical Supplies***.
Exhibit 114: Shareholding structure, governance structure, and organizational structure of Hangzhou Concord Medical Supplies***.
Exhibit 115: Overall operating conditions of Hangzhou Concord Medical Supplies***.
Exhibit 116: Overall business structure of Hangzhou Concord Medical Supplies***.
Exhibit 117: Hangzhou Concord Medical Supplies*** Medical Aesthetic Injection Business Technology, Products and Services Industrial Chain Layout.
Exhibit 118: Hangzhou Concord Medical Supplies*** Medical Aesthetic Injection Business Supply Layout.
Chart 119: Sales layout of Hangzhou Concord Medical Supplies*** Medical Aesthetic Injection Business.
Chart 120: Analysis of the advantages and disadvantages of Hangzhou Concord Medical Supplies*** medical aesthetic injection business layout.